Today’s the Final Day to Comment on the DEA’s Marijuana Rescheduling Proposal

Today marks the final day for the public to submit comments on the Drug Enforcement Administration’s (DEA) proposal to reschedule marijuana.

This comment period, a legally required 60-day window, was initiated on May 21 when the DEA published their proposal in the Federal Register. The comment period officially closes today, July 22, at 11:59 EDT. Comments can be submitted by clicking here.

Currently there are over 36,000 comments submitted. An analysis reveals that more than 50% of these comments advocate for the DEA to fully deschedule marijuana. When combined with those urging the DEA to legalize or decriminalize marijuana, the support rises to over 70%. In contrast, only 8% of comments oppose the proposal, arguing to maintain marijuana as a Schedule I drug.

Since the Controlled Substances Act was enacted in 1970, marijuana has been classified as a Schedule I substance, making it illegal for all purposes. The DEA’s current proposal to move marijuana to Schedule III would acknowledge its medical value, allowing its compounds and medicines to be prescribed nationwide upon regulatory approval. This reclassification would also offer federal protections to state-legal medical marijuana businesses and patients, including the ability for licensed marijuana businesses to take IRS tax deductions.

Once the public comment period closes on Monday, July 22, the DEA will then conduct a full review of each comment submitted. This process can take weeks or months, although it’s worth noting that President Biden ordered this to be reviewed “expeditiously”. After reviewing and assessing the comments, the DEA has the option of holding a public hearing on the matter, although this is not a legal requirement.

When the DEA reaches a final decision, they will announce it in the Federal Register, specifying the effective date of the change.

Polling data released in May indicates that two-thirds of U.S. voters support the move to reclassify marijuana.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales